SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Kanabo launches online CBD store for UK customers

    By
    Home / Kanabo launches online CBD store for UK customers

    UK-based Kanabo is launching the Kanabo.store platform for wellness CBD consumers, featuring the company’s VapePod it says is “game-changing” for consumers looking to improve their quality of life.

    The Kanabo.store will cater to the UK market initially and then roll out across Europe, giving CBD consumers access to Kanabo’s three proprietary CBD formula pods.

    The pods work with Kanabo’s unique VapePod, a first-of-its-kind medical grade vaporiser that provides easy-to-use metered dosing.

    Avihu Tamir, founder and CEO of Kanabo, stated: “Our VapePod is a game-changer for CBD consumers who aim to improve their health and quality of life.

    “No other CBD delivery system currently on the market offers the same precise, metered dosing solution that the VapePod consistently provides. We use the highest quality hemp-derived natural ingredients which makes the VapePod the most effective CBD delivery system in the world.”

    Kanabo was the first medicinal cannabis company to IPO on the London Stock Exchange, and recently made its acquisition of the online GP Service to help increase access to medical cannabis for patients. The company has made the VapePod to give a metered dose of 1mg on every inhalation, so consumers know the exact amount consumed – and exactly what they are inhaling.

    Read more: What does Kanabo’s telehealth approach mean for UK medical cannabis?

    With the rapid onset of cannabinoids delivered to the body by simply inhaling, the VapePod offers the shortest delivery time with noticeable effects via the pulmonary tract. The device cuts out as soon as it reads that 1mg of CBD has been inhaled. This feature is helpful for the use of medicinal cannabis as it allows physicians to confidently prescribe accurate and precise microdoses of cannabis and collect accurate patient data.

    The VapePod’s bioavailability is higher compared to other delivery methods as the body does not flush out a lot of the product as it can do with capsules or tinctures.

    The CBD Pods are manufactured in the UK and the portable and easy-to-use VapePod is discreet for social or work settings. Each CBD Pod contains 300 doses per unit and the hemp from which our broad-spectrum CBD is made contains minor cannabinoids and hemp terpenes that are naturally sourced and are manufactured at an EU-GMP facility, meeting the highest production standards worldwide. 

    Kanabo’s CBD formulas feature 80 per cent cannabinoids (360 mg of CBD) and are made with only pure hemp ingredients; 100 per cent vegan and without any commonly added diluents such as harmful PG, VG, MCT or PEG oils.

    [activecampaign form=31]

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free